One of the most important conferences in the North American vaccine industry is the annual WVC in Washington. Here, scientists and decision makers meet to discuss the latest innovation and development. Eurocine Vaccines´ CSO, Dr. Anna-Karin Maltais, will contribute with the latest results from our clinical study with Immunose™ FLU, our first product candidate based on our technology platform Endocine™. She will also share information about our next clinical trial and the latest developments within the area of nasal vaccination.

Read more about the conference at World Vaccine Congress, Washington

See our Press release about the upcoming study here =>